Outset Medical (NSDQ:OM) posted first-quarter results that beat the overall consensus on Wall Street and increased its guidance. The San Jose, Calif.-based Tablo dialysis machine maker reported losses of -$30 million, or -70¢ per share, on sales of $22.9 million for the three months ended March 31, for a sales growth of 218.72% compared with […]
Outset Medical
Outset Medical closes $149.7M public offering
Outset Medical (NSDQ:OM) announced that it closed a previously announced underwritten public offering with proceeds of approximately $149.7 million. San Jose, Calif.–based Outset offered 2.9 million shares of common stock sold by the company itself, plus nearly 3.9 million shares of its common stock sold by certain stockholders at a public offering price of $53.50 per […]
MedTech 100 roundup: Industry roars back
In the blink of an eye, the medtech industry exited its spring slump and neared its all-time best performance levels. MassDevice‘s MedTech 100 Index offered signs of a rebound last week and has built on that momentum, registering a final tally of 109.39 points on April 9. That represents a 2.9% increase from the 106.26-point mark […]
Outset Medical to raise nearly $366M from primary, upsized offerings
Outset Medical (NSDQ:OM) announced today that it priced an underwritten public offering of shares of its common stock. San Jose, Calif.–based Outset — maker of the Tablo hemodialysis system — is offering 2.5 million shares of common stock sold by the company itself, plus more than 3.4 million shares of its common stock sold by […]
The 10 most popular DeviceTalks Weekly Podcast episodes of 2020
Without the ability to gather for events and meetings, the DeviceTalks team launched the DeviceTalks Weekly Podcast to keep our medtech community talking. Over the span of 9 months and 39 episodes, we interviewed dozens of medtech leaders from startups to multinational corporations to hear how they’re managing through the challenges of 2020. Our episodes […]
MedTech 100 roundup: Stagnant week for industry
Medtech stocks made a run at a new peak over the past week, but ultimately remained mostly unchanged from the previous seven days. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 89.3 (Sep. 18), marking a 0.3% gain from the 89.03 points registered at […]
DTW Podcast: 3 lessons learned from Leslie Trigg, CEO of Outset Medical
Outset Medical (NSDQ:OM) CEO Leslie Trigg took the helm at the dialysis start-up in 2013, moving from an executive-in-residence post at private equity firm Warburg Pincus. Before that she held senior positions at Lutonix, AccessClosure and FoxHollow, helping to position those companies to be acquired by CR Bard, Cardinal Health, and ev3/Covidien, respectively. This week, […]
The top 5 MassDevice stories of the week — September 18, 2020
The past week in medtech saw a major IPO and a grim reminder about the importance of cybersecurity. Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss the week’s “Newmarker’s Newsmakers” during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top Five: 5. […]
Outset Medical IPO raises nearly $278M
Outset Medical (NSDQ:OM) has brought in nearly $278 million from its IPO that closed today, two days after its shares started trading on the Nasdaq. The maker of the Tablo hemodialysis system raised$277.9 million before deducting underwriting discounts and commissions and offering expenses. The nearly 10.3 million OM shares sold at an initial offering price […]
Outset Medical at-home dialysis system wins FDA approval
Outset Medical announced that it won expanded FDA clearance for patient use in the home with its Tablo hemodialysis system. Tablo’s existing indication included use in acute and chronic care facilities but, amid the COVID-19 pandemic, can now offer hemodialysis treatment from the home as in-hospital treatment is more of a challenge under current circumstances. […]
Outset Medical raises $125m for its all-in-one dialysis system
Outset Medical has raised $125 million in a Series E equity financing round that will help support the commercial expansion of the Tablo hemodialysis system in the U.S. D1 Capital Partners led the round, with Fidelity Management and Research C., Partner Fund Management, Perceptive Advisors, and funds advised by T. Rowe Price Associates also participating. […]
